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ABSTRACT
One of the largest challenges to the 
field of musculoskeletal ultrasonogra-
phy is attempting to accurately quantify 
the changes seen in chronic arthritis. 
With advances in ultrasound technol-
ogy, researchers have been increasingly 
exploring ways of more accurately as-
sessing these changes and attempting 
to reach consensus with agreed scoring 
systems. This review presents the main 
scoring systems developed for quantify-
ing sonographic findings indicative of 
synovitis and joint damage in patients 
with rheumatoid arthritis. Further in-
vestigation is required to attain inter-
national consensus on such scoring 
systems and to evaluate their impact on 
therapeutic decision-making.
Introduction
One of the largest challenges to the 
field of musculoskeletal ultrasonogra-
phy (US) is attempting to accurately 
quantify the changes seen in inflam-
matory diseases such as rheumatoid 
arthritis (RA). The hallmark changes 
seen in inflammatory arthritis with 
US include synovitis and bone erosion 
(1). With advances in US technology, 
researchers have been increasingly 
exploring ways of more accurately as-
sessing these changes and attempting 
to reach consensus with agreed scoring 
systems. In more recent times there has 
also been a move towards quantifying 
US findings characteristically seen in 
other musculoskeletal disorders e.g., 
osteoarthritis (OA).
Quantification of joint synovitis
It is well recognised in the literature 
that the metacarpo-phalangeal (MCP) 
and proximal inter-phalangeal (PIP) 
joints are amongst the most common 
targets for synovitis in early RA (2, 3). 
Using plain radiography standardised 
scoring systems for MCP and PIP joint 
damage exist and are in regular usage 
but there is no reliable index of soft tis-
sue involvement (4-6). 
A semi-quantitative scoring system, 
known as the RAMRIS, has already 
been agreed to by the Outcome Meas-
ures in Rheumatology Clinical Trials 
(OMERACT) group for synovitis in 
RA using magnetic resonance imaging 
(MRI) (7). This evaluates 3 compart-
ments of the wrist and all MCP joints 
and excludes PIP joints. 
Increasingly US is being used to identi-
fy early changes in inflammatory arthri-
tis and would appear to be as sensitive 
as MRI for detecting synovitis and joint 
erosion (8-11) given that US is more 
accessible than MRI and more practical 
a modality for patient follow-up. How-
ever, US sensitivity is strongly related 
to the width of the acoustic windows.
Several methods for quantifying joint 
synovitis in RA have been described, 
most of them employing a semi-quan-
titative scale from 0 to 3. Szkudlarek’s 
methods evaluated only 5 different 
joints (second and third MCP, second 
PIP and first and second metatarso-
phalangeal (MTP) joints) and made no 
allowance for the common co-exist-
ence of synovitis and effusion (12). 
One of the most commonly used meth-
ods for evaluation of joint synovitis in 
RA is the one described by Scheel as 
follows:
• The second-fifth MCP and PIP joint 
was examined using high frequency 
linear US probe.
• Two views were evaluated in each 
joint: longitudinal and transverse.
• The degree of synovial hypertrophy 
and joint effusion were scored 
 0 = no effusion/ hypertrophy, 
 1 = minimal effusion/ hypertrophy, 
2 = moderate effusion/ hypertrophy, 
3 = extensive effusion/ hypertrophy.
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Quantification of power Doppler 
signal
Power Doppler (PD) has been investi-
gated in several studies and has a posi-
tive correlation with synovial blood 
flow and therefore linked intimately 
with disease activity in inflammatory 
arthritis (14-16). It also appears to cor-
relate well with contrast enhanced MRI 
(17, 18).
There are essentially two different 
methods available for quantifying PD: 
visual and computerised. Within the 
clinical setting the visual semi-quan-
titative score is the most useful and 
readily available one. Different semi-
quantitative scoring systems have been 
proposed which involve the visual 
estimation of either pixilation (19) or 
number of visible vessels (20).
The method described by Szkudlarek 
et al. is perhaps the most universally 
recognised scoring system and is per-
formed as follows:
• The joint to be examined is scanned 
to obtain the standardised views in 
both the longitudinal and transverse 
planes.
• Accidental vessel compression must 
be ensured and either a thick gel lay-
er (gel-bath) or a small jelly stand-
off pad applied to the overlying skin
• PD settings were standardized for 
each patient and optimized for de-
tection of synovial blood flow by ad-
justing colour gain, pulse repetition 
and flow optimization parameters
• The colour gain threshold was set at 
the level just above which no signal 
was seen within bone
• The degree of PD signal was graded 
thus: 
 0 = no flow in the synovium, 
 1 = single vessel signals, 
 2 = confluent vessel signal in less 
than half of the area of the synovium, 
3= vessel signal in more than half of 
the area of the synovium 
Computerised methods involve cap-
turing the US colour image, import-
ing it into a dedicated photo-package 
and using the software to differentiate 
and count the number of colour pix-
els against the greyscale background 
(21, 22). The software method requires 
standardisation of magnification and 
field of view. The serial use of this com-
puterised method of PD quantification 
is therefore frought with methodologi-
cal peril and for that reason there has 
been limited diffusion of this outwardly 
impressive development.
Three dimensional (3D) US has recent-
ly been introduced into the technologi-
cal repertoire of rheumatologist sonog-
raphers and investigators have begun 
to explore its capabilities with PD (23, 
24). 3D US generates volumetric im-
ages containing the entire PD signal 
within the acoustic window represent-
ing the summation of a virtually infinite 
number of conventional two-dimen-
sional images. The peculiar automatic 
process of acquisition in 3D US sig-
nificantly reduces the margin for error 
and it is likely to be increasingly used 
as an imaging tool for the monitoring 
of synovial perfusion in inflammatory 
arthritis (25).
Quantification of bone erosion
A sinister development for any patient 
with inflammatory arthritis, especially 
RA, is the appearance of bone erosion 
(26). It is well recognised that US can 
clearly identify bony erosion within 
the small joints (MCP, PIP and MTP 
joints) in patients with early RA and at 
a stage where conventional radiography 
is unable to (27). In RA the commonest 
joints affected are the second, third and 
fifth MCP and the fifth MTP joints. This 
may partly be explained by the physical 
restrictions to the substantial investiga-
tion of certain joints with US.
The OMERACT group has defined 
bone erosion as an intra-articular dis-
continuity of the bone surface that is 
visible in two perpendicular planes. 
Fig. 1. Healthy subject. High-resolution grey-scale ultrasound using a 18 MHz linear probe show-
ing anatomic details less than 1 mm in size. A. Longitudinal dorsal view of the metacarpophalangeal 
joint in maximal flexion visualizing a subtle anechoic layer of 0.4 mm covering the metacarpal head. 
B. Transverse dorsal view of the head of the proximal phalanx. The hyaline cartilage is 0.12 mm thick. 
The arrowheads indicate the chondro-synovial interface appearing as a thin hyperechoic line at the 
areas of the cartilage surface perpendicular to the ultrasound beam direction. 
m = metacarpal head; p = proximal phalanx; t = finger extensor tendon.
For further ultrasound images, go to www.clinexprheumatol.org/ultrasound
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Wakefield et al. suggested a simple 
quantitative scoring system for estimat-
ing the dimensions of bone erosions seen 
in RA using the widest measured break 
in cortical continuity in millimetres:
• Small erosion = <2mm
• Moderate erosion = 2-4mm
• Large erosion = >4mm
With the advent of new generation very 
high frequency linear transducers ero-
sions can now be seen at dimensions 
<1mm. Furthermore, detailed explora-
tion of articular cartilage is also now 
possible permitting early and subtle 
changes within its echotexture to be 
clearly defined thereby heralding the ar-
rival of ‘acoustic microscopy’ (Fig. 1).
Quantification of response to 
treatment: short term monitoring
In the last few years the medical litera-
ture has become more populated with 
studies specifically addressing the area 
of US in short-term therapy monitoring 
of inflammatory arthritis (28-36). Treat-
ment with direct intra-articular infiltra-
tion with corticosteroid and systemic 
therapy with anti-tumour necrosis fac-
tor (TNF) agents have been investigated 
using US as an index of response. 
Ribbens et al. investigated 11 patients 
with active RA commencing treatment 
with anti-TNF therapy (infliximab) and 
monitored changes in synovial thick-
ness and PD in MCP, PIP and wrist 
joints at 6 weeks (31). The most sig-
nificant improvement was seen with 
reduction in synovial thickness using 
grey-scale measurement (p<0.1). A 
longer term US follow up of RA pa-
tients treated with an alternative anti-
TNF agent, etanercept, was performed 
by Terslev et al. and showed that whilst 
a reduction in PD activity could be 
seen at 2 weeks there was no sustained 
reduction seen at one year (32). Again 
PD signal was used by Filippucci et al. 
to assess response to adalimumab ther-
apy in the wrist joints of 24 RA patients 
(34). Using the standard 4-point semi-
quantitative scale for PD signal signifi-
cant reductions in activity were seen 
over a 12-week period which appeared 
to correlate with clinical improvement. 
There would therefore appear to be a 
quantifiable change in synovial vas-
cularity which occurs rapidly after 
institution of potent immunomodula-
tors in RA and this appears to corre-
late with clinical improvement. The 
challenge to investigators currently is 
defining the role of US and PD in the 
more medium term follow-up of pa-
tients with inflammatory arthritis and 
the influence upon subsequent manage-
ment decisions based on US findings.
Ultrasound measurements in 
osteoarthritis
The US study of OA has always inter-
ested rheumatologist sonographers and 
studies dating back over the last dec-
ade demonstrate (37-42). Many of the 
characteristic features of OA seen on 
plain radiography are easily identified 
with US including joint space narrow-
ing and, osteophytosis (42). Research-
ers have postulated for many years on 
the potential inflammatory component 
in the pathogenesis of OA and recently 
investigators have been able to depict 
this using PD US and quantify it. 
A pan-European multi-centre study in-
vestigated 600 patients with knee OA 
and defined knee synovitis as synovial 
thickness ≥4mm and joint effusion as 
effusion ≥4mm within the supra-patel-
lar recess. By these parameters 2.7% 
had synovitis alone, 14.2% had both 
synovitis and effusion, 29.5% had joint 
effusion alone and 53.7% no inflamma-
tion detected (43).
Further interest has centred on using 
US in hand OA. An expert group of 
rheumatologists, under the auspices of 
the Disease Characteristics in Hand OA 
Group (DICHOA), has initiated the pri-
mordial stages in the development of a 
US hand scoring system via an iterative 
internet exercise (44). They decided that 
the most important features of hand OA 
to be included in this system were grey-
scale synovitis, power Doppler and os-
teophytosis. US changes within articu-
lar cartilage and joint space narrowing 
were not felt to be reliable measures 
and have been excluded from further 
deliberation. The final report from this 
group will be much anticipated.
Conclusion
US is now a well established investiga-
tive tool within the rheumatologists’s 
armamentarium and the pathological 
features which it displays will continue 
to play an important role in influencing 
patient management. Establishing ac-
curate measurement of these findings 
seems vital particularly when clinical 
comparators are necessary at follow-
up. The growing number of scales and 
grading systems in musculoskeletal US 
will require further validation and their 
impact on therapeutic decision-making 
fully explored.
Links
For ultrasound images, go to: 
www.clinexprheumatol.org/ultrasound 
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